Grace Announces New BioFuel Technologies Group
Grace Davison, an operating segment of W. R. Grace & Co., has established the BioFuel Technologies Group that will oversee intensified product development in the renewable fuels industry.
Grace Davison, an operating segment of W. R. Grace & Co., has established the BioFuel Technologies Group that will oversee intensified product development in the renewable fuels industry.
The BioFuel Technologies Group is the flagship project of the Incubator Technology program at Grace that develops technology and products through a combination of R&D and business development. The first areas the BioFuel Technologies Group will focus on include catalysts and adsorbents for enhanced biodiesel and bioethanol production, as well as chromatography-based analytical and quality control tools.
"Our enabling technologies hold tremendous potential to help biorefineries efficiently manufacture alternatives to gasoline and diesel that promote sustainable, clean and secure energy sources," said Greg Poling, President of Grace Davison. ?The company?s century-long history of materials science expertise creates a solid foundation for expansion in the biofuels market. The creation of the BioFuel Technologies Group reaffirms the company?s strong commitment to environmental stewardship.?
The BioFuel Technologies Group combines previous efforts across product lines, leveraging the company?s existing global infrastructure and enabling Grace to offer integrated customer solutions and technical support. The BioFuel Technologies Group is positioned to capitalize on an estimated average growth rate of 15% in the biofuels industry, as reported by a study prepared by the Worldwatch Institute.
Grace is a leading global supplier of catalysts and other products and services to petroleum refiners; catalysts for the manufacture of plastics; silica-based engineered and specialty materials for a wide-range of industrial applications; specialty chemicals, additives and materials for commercial and residential construction; and can sealants and coatings for food packaging. With annual sales of more than $2.5 billion, Grace has over 6,400 employees in nearly 40 countries. For more information, visit Grace's web site at www.grace.com.
Mitigating High Sample Volume Consumption in AAV Aggregate Analysis Using a Biozen™ dSEC-7 by SEC-FL
April 15th 2024This application note showcases a Biozen dSEC-7 SEC chemistry/fluorescence detector solution, offering reliable AAV aggregate analysis in under 10 minutes with as little as 0.5 µL of sample. Across four AAV serotypes, resolution between monomer and aggregates remains consistently high, emphasizing Biozen dSEC-7's efficiency and ability to maintain accurate detection at minimal injection volumes. Ideal for routine testing, this solution ensures precise measurement of a CQA with streamlined sample consumption.
Adeno-Associated Virus (AAV) Serotype Screen Using a Biozen™ dSEC-7 Size Exclusion Column
April 15th 2024With its 700 Å large pore silica particle and hydrophilic diol-type surface chemistry, Biozen dSEC-7 provides excellent resolution of monomer from dimer peaks in under 8 minutes across four different AAV serotypes. This capability is crucial for optimizing gene therapy biopharmaceuticals, ensuring thorough analytical scrutiny to select the most appropriate serotype(s) for enhanced therapeutic outcomes and immunogenic profiles.
